For research use only
| Cat No. | ABC-TC5585 |
| Product Type | Human Liver Cancer Cell Lines |
| Cell Type | Epithelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Liver |
| Disease | Hepatocellular Cancer |
| Product Code | Hep 3B2_1-7; HEP3B217; Hep 3B2; HEP-3B2; HEP3B2; Hep-3B; HEP-3B; Hep 3B; Hep3B; HEP3B |
Hep 3B is a human hepatocellular carcinoma line, aneuploid with integrated HBV, expresses AFP and albumin, tumorigenic in nude mice, cancer model tool.
Hep 3B is a human hepatoma cell line originally derived from liver tissue obtained from an 8-year-old Black patient with liver cancer.Hep 3B, also known as Hep 3B2.1-7, is a human hepatocellular carcinoma (HCC) cell line derived from the liver tissue of an 8-year-old Black male patient diagnosed with liver cancer. These cells exhibits epithelial-like morphology and display typical adherent culture properties in vitro. Crytogenetically, Hep3B cells possess an aneuploid karyotype with an average chromosomal count of 60. Notably, Hep 3B harbors an integrated hepatitis B virus (HBV) genome and expresses high levels of hepatocyte-associated markers including alpha-fetoprotein (AFP), hepatitis B surface antigen (HBsAg), albumin, and transferrin protein. Hep 3B is tumorigenic, and capable to form tumors in immunodeficient (nude) mice, undercoring its utility in cancer modeling.
| Product Code | Hep 3B2_1-7; HEP3B217; Hep 3B2; HEP-3B2; HEP3B2; Hep-3B; HEP-3B; Hep 3B; Hep3B; HEP3B |
| Species | Human |
| Cat.No | ABC-TC5585 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Liver |
| Disease | Hepatocellular Cancer |
| Biosafety Level | 2 |
| Storage | Liquid Nitrogen |
| Product Type | Human Liver Cancer Cell Lines |
Hep 3B cell line are a valuable resource for a broad spectrum of hepatology and oncology research applications. They serve as a robust in vitro model for studying the molecular mechanisms of HBV-associated hepatocarcinogenesis, enabling researchers to explore the interplay between viral integration and tumor progression. Additionally, these cells is widely used in drug metabolism, hepatotoxicity studies, and the analysis of plasma protein biosynthesis, particularly in relation to liver-specific functions. Its tumorigenic properties and stable expression of liver-specific markers make these cells an indispensable platform for developing anticancer therapies, antiviral strategies, and understanding liver pathophysiology.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
